Relay Therapeutics: Platform More Important Than Programs [Seeking Alpha]
Relay Therapeutics, Inc. (RLAY)
Company Research
Source: Seeking Alpha
The company is developing small molecule drugs for oncology, but its platform has broader applicability. Relay's stock has declined significantly since listing due to the combination of a difficult macro environment and a lack of positive clinical data. Sentiment appears to be overly bearish given Relay's long-term potential, although it could take the company several years to build data that supports its approach. After declining significantly on the back of poor clinical data, Relay Therapeutics' ( NASDAQ: RLAY ) stock has been treading water over the past 10 months. Investors appear to be overly focused on the progress of individual drugs, rather than Relay's structure-based drug design platform, which seeks to leverage an understanding of protein motion. For better or worse, it will likely take years for the merits of Relay's approach to be fully understood, though. Overview Relay is a drug discovery company leveraging technology to develop precision medicines, with an i
Show less
Read more
Impact Snapshot
Event Time:
RLAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RLAY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RLAY alerts
High impacting Relay Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
RLAY
News
- Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024GlobeNewswire
- Relay Therapeutics to Participate in Upcoming Investor ConferencesGlobeNewswire
- Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.MarketBeat
- Relay Therapeutics to Participate in Three Upcoming Investor ConferencesGlobeNewswire
- Relay Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
RLAY
Earnings
- 2/22/24 - Beat
RLAY
Analyst Actions
- 2/22/24 - Stifel
RLAY
Sec Filings
- 4/23/24 - Form ARS
- 4/23/24 - Form DEFA14A
- 4/23/24 - Form DEF
- RLAY's page on the SEC website